Surmodics(SRDX)

Search documents
Surmodics(SRDX) - 2021 Q4 - Earnings Call Transcript
2021-11-10 18:59
Surmodics, Inc. (NASDAQ:SRDX) Q4 2021 Earnings Conference Call November 10, 2021 8:30 AM ET Company Participants Tim Arens – Senior Vice President-Finance and Chief Financial Officer Gary Maharaj – President and Chief Executive Officer Conference Call Participants Brooks O’Neil – Lake Street Capital Markets Mike Matson – Needham and Company Jim Sidoti – Sidoti & Company Mike Petusky – Barrington Research Operator Good day, and welcome to the Surmodics Fourth Quarter Fiscal 2021 Earnings Conference Call. Tod ...
Surmodics(SRDX) - 2021 Q2 - Earnings Call Presentation
2021-08-10 11:55
| --- | --- | --- | |--------------------------------------------------------|-------|-------| | | | | | | | | | | | | | Gary Maharaj President and CEO | | | | Tim Arens Senior Vice President of Finance, IT and CFO | | | | AUGUST 2021 | | | © 2021 Surmodics, Inc. CONFIDENTIAL All rights reserved. SAFE HARBOR Some of the statements made during this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not hist ...
Surmodics(SRDX) - 2021 Q3 - Earnings Call Transcript
2021-08-07 16:37
Surmodics, Inc. (NASDAQ:SRDX) Q3 2021 Results Conference Call August 4, 2021 8:30 AM ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Mike Matson - Needham & Company Brooks O'Neil - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Operator Good day, everyone, and thank you for standing by. Welcome to the Surmodics Third Quarter Fiscal 2021 Earnings Conference Call. Toda ...
Surmodics(SRDX) - 2021 Q3 - Quarterly Report
2021-08-04 12:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identi ...
Surmodics(SRDX) - 2021 Q2 - Earnings Call Transcript
2021-04-28 21:53
Surmodics, Inc. (NASDAQ:SRDX) Q2 2021 Earnings Conference Call April 28, 2021 8:30 AM ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Mike Matson - Needham & Company Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Operator Good day and welcome to the Surmodics Second Quarter Fiscal 2021 Earnings Conference Call. Tod ...
Surmodics(SRDX) - 2021 Q2 - Quarterly Report
2021-04-28 19:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Ident ...
Surmodics(SRDX) - 2021 Q1 - Earnings Call Transcript
2021-02-09 18:07
Surmodics, Inc. (NASDAQ:SRDX) Q1 2021 Earnings Conference Call February 9, 2021 8:30 AM ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Mike Matson - Needham & Company Brooks O'Neil - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Mike Petusky - Barrington Research Operator Good day and welcome to the Surmodics First Quarter Fiscal 2021 Earnings Conference Call. Today ...
Surmodics(SRDX) - 2021 Q1 - Quarterly Report
2021-02-09 13:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Id ...
Surmodics(SRDX) - 2020 Q4 - Earnings Call Presentation
2020-11-06 17:13
| --- | --- | |--------------------------------------------------------|-------| | | | | Gary Maharaj President and CEO | | | Tim Arens Senior Vice President of Finance, IT and CFO | | | NOVEMBER 2020 | | 2 SAFE HARBOR Some of the statements made during this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical or current facts, including statements about our vision and its impact to investors, ...
Surmodics(SRDX) - 2020 Q4 - Earnings Call Transcript
2020-11-05 04:50
Surmodics, Inc. (NASDAQ:SRDX) Q4 2020 Earnings Conference Call November 4, 2020 5:00 PM ET Company Participants Timothy Arens - Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Thomas Greaney - Chief Operating Officer of Medical Devices Conference Call Participants Brooks OÂ'Neil - Lake Street Capital Markets David Saxon - Needham & Company Operator Good day and welcome to the Surmodics Fourth Quarter Fiscal 2020 Earnings Conference Call. TodayÂ's conference is being recorded. At ...